Anak Agung Ayu Putri Laksmidewi
Department of Neurology, Faculty of Medicine, Universitas Udayana, Denpasar, Indonesia

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

Heart Rate Variability in Insomnia and Poor Sleep Quality versus Controls: An Updated Meta-Analysis of Case-Control and Cross-Sectional Studies Using Standardised Mean Differences Orlando Pikatan; Desak Ketut Indrasari Utami; Anak Agung Ayu Putri Laksmidewi
Sriwijaya Journal of Neurology Vol. 3 No. 2 (2026): Sriwijaya Journal of Neurology
Publisher : Phlox Institute: Indonesian Medical Research Organization

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59345/sjn.v3i2.275

Abstract

Introduction: Chronic insomnia is linked to autonomic dysregulation and to elevated cardiovascular and cerebrovascular risk. Reduced heart rate variability (HRV), particularly its vagal component, has been proposed as a peripheral marker of the central hyperarousal of insomnia, but the quantitative evidence is inconsistent and the only prior pooled estimate used an unconventional method. This study aimed to provide an updated, conventionally pooled estimate of the HRV difference between adults with insomnia or poor sleep and controls, and to test whether it depends on insomnia severity. Methods: PubMed/MEDLINE was searched (cross-checked against Scopus and Web of Science) for case-control and cross-sectional studies comparing HRV between adults with insomnia or poor sleep and non-insomnia controls. Six studies with verified, openly accessible, extractable per-group data were pooled. Hedges’ g standardised mean differences were combined under a random-effects model (DerSimonian-Laird), with restricted maximum likelihood and the Hartung-Knapp adjustment as robustness checks. The primary outcome was composite vagal HRV; secondary outcomes were SDNN, the LF/HF ratio and mean heart rate. A pre-specified severity subgroup, leave-one-out, prediction interval, Egger test and Newcastle-Ottawa appraisal were performed. The review was not registered. Results: Six studies (484 with insomnia/poor sleep; 365 controls) were pooled. Composite vagal HRV was lower in insomnia/poor sleep (g = -0.58, 95% CI -1.19 to 0.03; I² = 93.7%). The effect was concentrated in clinically diagnosed insomnia (g = -1.04) and near-null in poor sleep (g = -0.10). Removing one elite-athlete outlier yielded a significant, homogeneous estimate (g = -0.29, 95% CI -0.56 to -0.01, p = 0.039; I² = 59%). SDNN, LF/HF and heart rate did not differ. The estimate bracketed the previously published value (SMD -0.41). Conclusion: Vagal HRV is reduced in insomnia and poor sleep, with a clinically meaningful effect confined to diagnosed insomnia disorder. Low vagal HRV is a candidate autonomic marker linking insomnia to vascular risk, although high heterogeneity and low certainty warrant cautious interpretation.
Admission Mean Platelet Volume and Poor Functional Outcome After Reperfusion Therapy for Acute Ischaemic Stroke: A Systematic Review and Meta-Analysis Ivan Agusta Dwi Kristiawan; Kumara Tini; Ida Ayu Sri Wijayanti; Anak Agung Ayu Putri Laksmidewi; Ketut Widyastuti; Ni Putu Ayu Putri Mahadewi
Sriwijaya Journal of Neurology Vol. 4 No. 1 (2026): Sriwijaya Journal of Neurology
Publisher : Phlox Institute: Indonesian Medical Research Organization

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.59345/sjn.v4i1.309

Abstract

Background: Mean platelet volume (MPV), an inexpensive index of platelet activation from the routine admission full blood count, has been linked to poor outcome in unselected ischaemic stroke, but its prognostic value in reperfusion-treated patients is uncertain and conflicting. Objective: To quantify the association between admission MPV and poor functional outcome after reperfusion therapy, and to test whether it depends on treatment modality and MPV operationalisation. Methods: PubMed was searched for cohort or case–control studies reporting admission MPV against poor functional outcome (modified Rankin Scale 3–6) in adults with acute ischaemic stroke treated with intravenous thrombolysis and/or mechanical thrombectomy. Odds ratios (OR) were pooled using DerSimonian–Laird random-effects models, with a-priori subgroups by modality and MPV metric and leave-one-out, adjusted-only and Hartung–Knapp sensitivity analyses. This review was not registered in a public registry. Results: Ten studies were included and seven (1,597 patients) pooled. Higher MPV was associated with poor outcome (OR 1.62, 95% CI 1.22–2.16; I²=68.5%). The effect was strong with dichotomised MPV after thrombectomy (OR 2.56, 95% CI 1.60–4.08) but modest with continuous or quartile MPV in broad reperfusion (OR 1.27, 95% CI 1.08–1.49); the between-subgroup difference was significant (p=0.005) yet not robust to removing the most weighted study per arm. Conclusion: Higher admission MPV was associated with poor functional outcome after reperfusion therapy, but its magnitude depended on modality and measurement; certainty was low (GRADE). MPV is a promising, essentially free supplementary marker best used within multivariable models, requiring confirmation in standardised prospective studies.